Biotech Values

[Titan V]

I agree on the need for a larger trial. Just a small observation btw, and I may be reading too much into it, but their January PR started describing the results with “To date...” so I’m just curious if the number of patients who were treated with Nivo will increase by a few more come AACR. Would still be a small sample anyway.